Óxido nítrico inhalado para el tratamiento postoperatorio de la hipertensión pulmonar en lactantes y niños con cardiopatía congénita
Información
- DOI:
- https://doi.org/10.1002/14651858.CD005055.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 19 octubre 2005see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Anestesia
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Conceiving the review: Dr Matthew J. Bizzarro (MB)
Co‐ordinating the review: (MB)
Undertaking manual searches: (MB)
Screening search results:(MB) and Dr Ian Gross (IG)
Organizing retrieval of papers: (MB)
Screening retrieved papers against inclusion criteria: D (MB)
Appraising quality of papers: (MB and IG)
Abstracting data from papers: (MB)
Writing to authors of papers for additional information: (MB)
Providing additional data about papers: (MB)
Obtaining and screening data on unpublished studies: (MB)
Data management for the review: (MB)
Entering data into Review Manager (RevMan 4.2): (MB)
RevMan statistical data: (MB)
Other statistical analysis not using RevMan:(MB)
Double entry of data: (MB and IG)
Interpretation of data: (MB and IG)
Statistical inferences: (MB)
Writing the review: (MB)
Securing funding for the review: N/A
Performing previous work that was the foundation of the present study: (MB)
Guarantor for the review (one author): (MB)
Person responsible for reading and checking review before submission: (MB and IG)
Sources of support
Internal sources
-
Yale University School of Medicine, USA.
External sources
-
No sources of support supplied
Declaraciones de interés
Ninguno conocido.
Agradecimientos
Se agradece al Dr. Mathew Zacharias, Prof. Marcus Müllner, Dr. Tom Pedersen, Dra. Karen Burns, Dr. Keith Barrington y a los revisores por pares y panel de consumidores del Grupo Cochrane de Corazón (Cochrane Heart Group) por su ayuda y asesoramiento editorial durante la preparación del protocolo. También se agradece al Dr. Mathew Zacharias, Dr. Keith Barrington, Dr. Ronald Day, Dr. Robert Tulloh, Prof. Nathan Pace, Kathie Godfrey, Janet Wale y Jane Cracknell por su colaboración y observaciones editoriales durante la preparación de esta revisión.
Se agradece al Dr. Ronald Day por la contribución de sus datos de pacientes individuales para el análisis y la inclusión en esta revisión.
También se agradece al Dr. Michael Bracken por su instrucción sobre los conceptos y principios de la medicina basada en pruebas y la preparación de una revisión sistemática, además de su ayuda estadística con los análisis de los datos.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Jul 03 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Review | Matthew Bizzarro, Ian Gross, Fabiano T Barbosa | |
| 2005 Oct 19 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Review | Matthew Bizzarro, Ian Gross | |
| 2004 Apr 19 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Protocol | Matthew Bizzarro, Ian Gross | |
Differences between protocol and review
No data were available for some of the outcomes desired for analysis, including long‐term mortality, length of hospital stay, and incidence and severity of neurodevelopmental disability.
Notes
None
